IMMUNOVIA AB NPV financial statements, including revenue, expenses, profit, and loss

The total revenue of 0G8X for the last quarter is 235.00 k SEK, and it's 176.47% higher compared to the previous quarter. The net income of Q3 24 is -51.07 M SEK.